Novel mediators of FTY720 in human lymphocytesBÖHLER, Torsten; BUDDE, Klemens; NEUMAYER, Hans-H et al.Transplantation. 2005, Vol 79, Num 4, pp 492-495, issn 0041-1337, 4 p.Article

Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipientsBÖHLER, Torsten; SCHÜTZ, Manuela; BUDDE, Klemens et al.International immunopharmacology. 2007, Vol 7, Num 1, pp 88-95, issn 1567-5769, 8 p.Article

The immunosuppressive potential of misoprostol: efficacy and variabilityWAISER, Johannes; BÖHLER, Torsten; STOLL, Juliane et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 3, pp 288-294, issn 1521-6616, 7 p.Article

FTY720 exerts differential effects on CD4⁺ and CD8⁺T-lymphocyte subpopulations expressing chemokine and adhesion receptorsBÖHLER, Torsten; WAISER, Johannes; SCHUETZ, Manuela et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 3, pp 702-713, issn 0931-0509, 12 p.Article

Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine AWAISER, Johannes; SCHNEIDER, Michael; ELJAZYFER, Sara et al.Clinical immunology (Orlando, Fla. Print). 2006, Vol 119, Num 1, pp 59-66, issn 1521-6616, 8 p.Article

FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: Different effects on CD62L⁺ and CCR5⁺ t lymphocytesBOHLER, Torsten; WAISER, Johannes; SCHÜTZ, Manuela et al.Transplantation. 2004, Vol 77, Num 9, pp 1424-1432, issn 0041-1337, 9 p.Article

Immunohistochemical double-staining of renal allograft tissue: critical assessment of three different protocolsWAISER, Johannes; SCHWAAR, Stefan; BÖHLER, Torsten et al.Virchows Archiv. 2002, Vol 440, Num 6, pp 648-654, issn 0945-6317Article

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcomeCANIVET, Cindy; ROSTAING, Lionel; KAMAR, Nassim et al.International immunopharmacology (Print). 2009, Vol 9, Num 9, pp 1131-1136, issn 1567-5769, 6 p.Article

Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalaprilKRÄMER, Stephanie; LOOF, Tanja; MARTINI, Sebastian et al.American journal of physiology. Renal physiology. 2005, Vol 58, Num 2, pp F359-F368, issn 1931-857XArticle

FTY720 (fingolimod) in renal transplantationBUDDE, Klemens; SCHÜTZ, Manuela; GLANDER, Petra et al.Clinical transplantation. 2006, Vol 20, pp 17-24, issn 0902-0063, 8 p., SUP17Article

FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injuryDRAGUN, Duska; BÖHLER, Torsten; NIEMINEN-KELHÄ, Melina et al.Kidney international. 2004, Vol 65, Num 3, pp 1076-1083, issn 0085-2538, 8 p.Article

Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failureMORGERA, Stanislao; HAASE, Michael; GÖHL, Hermann et al.Nephron. 2003, Vol 94, Num 3, pp c75-c80, issn 0028-2766Article

Cyclosporine A up-regulates the expression of TGF-β1 and its receptors type I and type II in rat mesangial cellsWAISER, Johannes; DELL, Kerstin; BÖHLER, Torsten et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 9, pp 1568-1577, issn 0931-0509Article

Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humansBOHLER, Torsten; NOTTING, Jochen; KAMAR, Nassim et al.Therapeutic drug monitoring. 2007, Vol 29, Num 1, pp 77-86, issn 0163-4356, 10 p.Article

FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1PCHEJETSKI, Dmitri; BOHLER, Torsten; CUVILLIER, Olivier et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 21, pp 8651-8661, issn 0008-5472, 11 p.Article